Category: Sin categoría

Spain will review its medical cannabis decree before the end of 2026. What could change in dispensing, and what it means for producers and labs.

France sent the medical cannabis reimbursement decree to the Conseil d’État on 2 July. No prescriptions under the permanent framework before 2027.

Brussels proposes recognising the whole hemp plant, flower included, as an agricultural product with CAP access. What changes for the sector from 2027.

BfArM has revised Q1 2026 upward to 67.5 tonnes imported. What Germany’s new record means for European producers, distributors and investors.

Curaleaf bids US$4.00 a share for Aurora to secure 50+ tonnes of EU-GMP capacity, while Canopy and SNDL certify plants. Europe now sets the price.

EFSA sets a provisional safe level of about 2 mg of CBD per day. What changes for hemp manufacturers, distributors and brands across the EU.

Spain schedules HHC, THC-O and H4-CBD, and the UN has controlled HHC since December 2025. What it changes for hemp and CBD businesses across Europe.

AEMPS registers Spain’s first two standardised cannabis preparations. Royal Decree 903/2025 moves from paper to hospital pharmacy supply.

Germany is finalising a law to ban telemedicine and mail-order medical cannabis, the channel that drove its imports up 176% in 2025.

The EU is finalising its biggest pharma reform in 20 years: 11-year exclusivity, a regulatory sandbox and new EU-GMP rules for medical cannabis.